Update on Optimal Use of Lisdexamfetamine in the Treatment of ADHD

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s34092
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search